Nitrostat and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrostat and Daliresp. Common interactions include hypertension among females and cardiac disorder among males.

The phase IV clinical study analyzes what interactions people who take Nitrostat and Daliresp have. It is created by eHealthMe based on reports of 62 people who take Nitrostat and Daliresp from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 08, 2023

62 people who take Nitrostat and Daliresp together, and have interactions are studied.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 13,156 Nitrostat users for its effectiveness, alternative drugs and more.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,078 Daliresp users for its effectiveness, alternative drugs and more.

Number of Nitrostat and Daliresp reports submitted per year:

Common Nitrostat and Daliresp drug interactions by gender *:

female:

Hypertension
Iron deficiency anaemia
Lung disorder
Magnesium deficiency
Malaise
Mobility decreased
Nephropathy
Respiratory disorder
Spinal fracture
Tubulointerstitial nephritis

male:

Cardiac disorder
Lung disorder
Rheumatoid arthritis
Weight decreased
Fall
Malaise
Spinal fracture
Obstruction
Respiratory tract infection
Blood pressure fluctuation

Common Nitrostat and Daliresp drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Cardiac disorder
Fall
Lung disorder
Malaise
Spinal fracture
Anxiety
Cardiac failure congestive
Hypercholesterolaemia
Hypertension
Hypothyroidism

20-29:

n/a

30-39:

n/a

40-49:

Anxiety
Bronchitis
Chronic kidney disease
Heart rate increased
Renal failure

50-59:

Hypothyroidism
Infection
Influenza
Migraine
Nephropathy
Nuclear magnetic resonance imaging brain
Pericardial effusion
Pleural effusion
Pruritus
Pulmonary sepsis

60+:

Renal failure
Asthenia
Weight decreased
Obstruction
Respiratory tract infection
Blood pressure fluctuation
Lip infection
Respiratory tract congestion
Skin infection
Chronic kidney disease

Common conditions people have *:

Immunodeficiency Common Variable: 17 people, 27.42%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 20.97%
Pain: 12 people, 19.35%
High Blood Cholesterol: 12 people, 19.35%
Hypersensitivity: 11 people, 17.74%
Stress And Anxiety: 11 people, 17.74%
High Blood Pressure: 10 people, 16.13%
Nausea (feeling of having an urge to vomit): 6 people, 9.68%
Asthma: 6 people, 9.68%
Stable Angina (a constant chest pain): 5 people, 8.06%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and Daliresp?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.